Fda Asthma-drug Ruling Affects Cornerstone

The U.S. Food and Drug Administration is now asking that makers of asthma drugs in a specific class of medications include a precaution in the labeling explaining that neuropsychiatric events have been reported in some patients taking these products – a ruling that affects Cary-based Cornerstone Therapeutics.

BING NEWS:
  • Exclusive-US FDA finds widely used asthma drug impacts the brain
    (Reuters) - U.S. government researchers have found that a widely prescribed asthma drug originally sold by Merck & Co may be linked to serious mental health problems for some patients, according to a ...
    12/6/2024 - 4:30 am | View Link
  • Popular asthma drug Singulair could be linked to mental health side effects, suicides: FDA
    Singulair, a popular asthma medication, could be linked to severe side effects, including suicide, a study from the FDA found.
    11/24/2024 - 10:05 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News